Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 1 Interventional

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

ClinicalTrials.gov ID: NCT06774963

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06774963. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open-label, Dose Escalation and Dose Expansion Study for LNCB74, a B7-H4 Targeted Antibody Drug Conjugate, as Monotherapy in Participants With Advanced Solid Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, phase 1, dose escalation and dose expansion study to determine safety and tolerability, and to determine the maximum tolerated dose and / or recommended phase 2 dose of LNCB74 in participants with advanced solid tumors.

Study identification

NCT ID
NCT06774963
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
LigaChem Biosciences, Inc.
Industry
Enrollment
145 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 7, 2025 (Actual)
Primary completion
Dec 2027 (Estimated)
Completion
Dec 2027 (Estimated)
Last update posted
Oct 29, 2026

2025 – 2027

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Hoag Family Cancer Institute Newport Beach California 92663 Completed
St. Elizabeth Healthcare Edgewood Kentucky 41017 Recruiting
Dana Farber Cancer Institute Boston Massachusetts 02215 Recruiting
Washington University, Siteman Cancer Center St Louis Missouri 63108 Recruiting
John Theurer Cancer Ctr at Hackensack Univ. Med Ctr. Hackensack New Jersey 07601 Not yet recruiting
Roswell Park Comprehensive Cancer Center Buffalo New York 14203 Recruiting
Mount Sinai Tisch Cancer Center New York New York 10011 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
Cleveland Clinic Taussig Cancer Institute Cleveland Ohio 44195 Recruiting
Sidney Kimmel Comprehensive Center at Jefferson Philadelphia Pennsylvania 19107 Recruiting
UPMC Pittsburgh Pennsylvania 15213 Recruiting
Sarah Cannon Research Institute Nashville Tennessee 37203 Recruiting
MD Anderson Houston Texas 77030 Recruiting
NEXT Oncology San Antonio Texas 78229 Completed
UT Health San Antonio - MD Anderson Cancer Center San Antonio Texas 78229 Recruiting
Intermountain/LDS Hospital Ph 1 Research Program Salt Lake City Utah 84143 Recruiting
Inova Schar Cancer Institute Falls Church Virginia 22031 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06774963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.